Global Hyperlipidemia Drugs Market Size study & Forecast, by Drug Class (Statins, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, Fibric Acid Derivatives, PCSK9 Inhibitors, Combination, Miscellaneous) and Regional Analysis, 2023-2030

Amgen Inc.
AstraZeneca PLC
Daiichi Sankyo Company Limited
Eli Lilly and Company
Esperion Therapeutics Inc
GlaxoSmithKline Pharmaceuticals Limited (GlaxoSmithKline Plc)
Immuron Limited
Ionis Pharmaceuticals Inc.
Merck & Co. Inc.
Sanofi S.A.